Press releases

• Bernd Dautel appointed as new Director
• Many years of experience, expertise and network of contacts

Frankfurt am Main / Singapore – 10 May 2012 – Bernd Dautel has been appointed to the Management Board of the Nanostart subsidiary Nanostart Asia Pacific as a new Director alongside Andreas Kröll. Born in Germany and living and working in Singapore for the last 17 years, Mr. Dautel will join Nanostart Asia Pacific on a full-time basis from the middle of the year.  

• von Volkmann leads Financial Department with immediate effect
• MagForce’s Financial Department will again be headed up by a competent leader

Frankfurt / Berlin, Germany – May 3, 2012 – MagForce AG (Frankfurt, XETRA: MF6), a leading medical technology company in the field of nanomedicine in oncology, announced today that Christian von Volkmann is hired as Head of Finance and will lead the Company’s Financial Department with immediate effect. Christian von Volkmann is a proven expert in finance with many years of experience in the biotech and pharma industries. In 2009, as Chief Financial Officer, he completed Jerini AG’s successful acquisition by Shire plc, which was initiated in 2008.

• Industrial coatings and contracted research to be combined into own entity
• Focus on customer-specific product developments with a prospect of in-house production

Frankfurt am Main / Saarbrücken, April 30, 2012 – The Nanostart holding ItN Nanovation AG (ISIN DE000A0JL461) will combine its previous activities in the area of industrial coatings and contracted research into an independent business entity as part of its announced restructuring. This will enable ItN to better satisfy the requirements of its customers. This will also result in a clear separation of the activities in the water area.

• New company formed: Nanostart Asia Pacific Pte Ltd
• Subsidiary Nanostart Asia and fund units contributed
• Strategic partners in Asia to provide experience, networks and capital

Frankfurt, Main / Singapore – April 26, 2012 – Nanostart AG is pressing ahead with its expansion in Asia and has formed a new company, Nanostart Asia Pacific Pte Ltd, together with investment partners. Nanostart is contributing its wholly-owned subsidiary Nanostart Asia Pte Ltd and its 50 per cent interest in Nanostart Singapore Early Stage Venture Fund, in exchange for which it will receive 56 per cent of the shares in the new Singapore-based company. The remaining 44 per cent will be held by partners in Singapore and other Asian countries, consisting of investors whose experience and networks will help Nanostart AG to achieve quick and easy expansion in Singapore and Asia.

Saarbrücken / Frankfurt am Main – April 3, 2012 – The Nanostart holding ItN Nanovation AG achieved its sales planning for the areas of coatings and contracted research in the 2011 fiscal year. However, in water filtration technology there were delays in the anticipated sales from Saudi Arabia. Overall, there was a year-on-year increase in sales of €107 thousand to €2,761 thousand. Sales in the water sector recorded a slight decline, while in the field of coatings they remained at the same level. Significant growth was posted in the field of contracted research.

• Medium-term financing secured through loan commitment
• Significant reduction of workforce
• Water filtration as core business area

Frankfurt / Saarbrücken – March 26, 2012. The board of directors of Nanostart holding ItN Nanovation AG (ISIN DE000A0JL461) – which recently received a shareholder loan, thereby securing the medium-term financing of the company – today resolved to implement a comprehensive repositioning program. ItN Nanovation will place a stronger focus than previously on the promising growth area of water filtration. Emphasis will be on existing groundwater filtration and wastewater treatment activities. The repositioning program also reduces the workforce from 62 to 37 employees. A loan commitment from a large shareholder will provide a financial foundation for this more focused business alignment.

• Greater emphasis on clinical development to provide key physicians with access to NanoTherm therapy
• Start of post marketing glioblastoma study Q3 2012 to support expanded market acceptance with leading medical experts
• Enhanced activities for international partnerships and initiation of discussions with FDA
• Focus on development partnerships and strategic investors to expand patient access and further reduce development costs
• Significant decrease in operating expenses expected in 2012 through headcount reduction

Frankfurt / Berlin – March 26, 2012 – Nanostart (OTCQX:NASRY)-holding MagForce AG (Frankfurt, XETRA: MF6), a leading medical technology company focusing on nanomedicine in oncology announced today the company’s restructuring and revised corporate strategy for 2012. The company reduced its headcount from 41 employees (year-end 2011) to 30 (April 1, 2012) and expects a significant reduction in company expenses in 2012 as compared to 2011. The implemented cost reductions will enable the company to work more effectively and concentrate on clinical development activities to support the market introduction of NanoTherm® therapy.

• Expansion of Management Board in order to manage growth
• Dr. Weiss appointed as CEO with responsibility for Finance
• Bungeroth intensifies activities in the areas of groundwater filtration, coatings and research

Frankfurt am Main / Saarbrücken – March 14, 2012 – The Supervisory Board of the Nanostart (OTCQX: NASRY) portfolio company ItN Nanovation AG (FSE: I7N) resolved yesterday to appoint Dr. Christoph Weiss (56) to the Management Board of ItN Nanovation AG for an initial term of two years.